Capital Impact Advisors, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2014$128,000
-2.3%
54,2000.0%0.06%–
Q3 2014$131,000
+72.4%
54,200
+100.0%
0.00%
-100.0%
Q2 2014$76,000–27,100–0.06%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2015.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders